skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning Peter n your wonderful team,
I sold my J&J shares recently due to the outstanding lawsuits against the company, I think of replacing it with Pfizer. What is your opinion on future of Pfizer’s earnings, growth n dividends, cash flow, pipelines of drugs, balance sheet etc. Or can you please suggest one or two drug companies that will provide some growth plus dividend income?

Thank again for your insight! Asked by Rossana.
Read Answer Asked by Rossana on August 02, 2018
Q: Good Morning,

I'm looking to add a few more US stocks to my portfolio. I'm adequately represented in tech and financial sectors. Could you give me 4 or 5 names in other sectors where above average growth might be expected.

Thanks for your help,

Dennis
Read Answer Asked by Dennis on July 30, 2018
Q: Good Afternoon,
I don't follow the US market that closely, I'm looking for a handful of safer blue chip dividend payers ? Such as AT&T , perhaps you can list a few other names in various sectors you feel are well managed companies with good yield.
Thank-you
Read Answer Asked by Chris on July 30, 2018
Q: Greetings 5i,

I sock away a bit of cash for the summer months as i find there is always a few opportunities to pick up a good companies at a discount. I limit this to a small portion of my portfolio but would like your recommendations on your top 5 CDn (growth) and 5 top US Dividend Payers (need US income) that you would pick up on a dip or low volume during the summer months? Last August was a great example of picking up really good names at a discount. I realize there are no guarantees that we will see the same market but always on the lookout to pick good long term names to add to my portfolio. In the past i have picked up Visa, JPM this way.

Thanks for your advice.
Read Answer Asked by kelly on June 01, 2018
Q: We have a 3.5% weighting in JNJ. We like it for its exposure to the USD, its steady dividend income, its blue-chip size and very modest share price growth. However I am concerned about the potential losses arising from their "baby-powder" lawsuit. We have owned the stock for years. I am thinking about switching out around 2% weighting into PFE. Its dividend appears to be higher and its chart seems to be better.
Reading over 5i responses on JNJ you seem fairly sanguine about JNJ so I hesitate to sell. We are retired but not currently spending our USD dividends - they are kept for foreign travel.
I must say I like XBI's chart. However its dividend is much lower so potentially we would need to sell stock if we needed USD. XBI should lower our risk profile as it is an ETF which is probably a smart move.
My questions are...
1) Would you recommend selling all our part of our JNJ or just do nothing?
2) Would you recommend purchasing PFE or XBI or both?
Please deduct as many credits as you feel my question(s) justify.
Thank you for your assistance.
Jim
Read Answer Asked by James on May 28, 2018
Q: I have a small position in PFE (about 1%), and I am interested in increasing my position to about 2%-2.5% by selling off a similarly-sized position in BAC. My portfolio has about a 10% weighting in financials, while I only have about 4% in health care, which is why I wanted to make the shift. My question is whether I am better off simply topping up my PFE position, or selling PFE as well as BAC, and using the proceeds to buy either JNJ, MRK or GSK. I prefer to stay with larger cap names, and in this particular case, I am looking at US names exclusively. If you have another larger cap US name that may be worth considering, I would be very open to suggestions.

As an aside, I also have a 3% position in GUD which I plan to keep for the longer term.

Thanks so much for your time, and I look forward to your response.
Read Answer Asked by Domenic on May 21, 2018
Q: I have Student Transportation in my US account. What would be some good US dividend Stocks and/or ETF's I could invest in to replace the lost dividends that I receive when it is sold later this month? I am looking at 3 or 4 stocks and 1 or 2 ETF's.
Thanks for the advice as it is always welcome.
Read Answer Asked by Kevin on April 25, 2018
Q: Hi Peter
Do you think it is time to buy back ENB.
What is your outlook for SHOP. I am thinking of adding to my position.
I don't have any health stock at the moment, do you have any suggestions?
Thanks
Margita
Read Answer Asked by Margita Elisabet on April 19, 2018
Q: Good Morning. I have US $ that I would like to invest. Would you please provide me with your top 5, any sector, growth but not too risky companies?
Thank you.
Cathy
Read Answer Asked by Catherine on March 28, 2018
Q: Hi, I want to increase my sector weightings in Manufacturing and Industrial stocks, plus obtain some Income. I currently hold Barrick ($7K); CAE ($37K); CNR ($58K), Intel ($20K); Pfizer($17K)and Wajax ($10K). Looking to invest $40K more in this area, your suggestions would be appreciated. Thanks!
Read Answer Asked by Kim on June 22, 2017
Q: Hi, I have the above stock in non registered account. As of today I lost $4000 US , bought it at 102 and now $67 $ US. What do you recommend? Sell it and claim loss or wait till it recover or add more to it. I added to it when it became $70 US. But it seems it is not doing well. I appreciate your ultimate decision on it or if there is any US solid stocks that you recommend. Thanks
Read Answer Asked by Adam on April 19, 2017
Q: Peter and Team,

I hold basically the balanced equity portfolio with CSW.A,KBL,and L added plus a portfolio I've been building to US/International. In the US/International portfolio I currently hold XYL, SBUX, V, JNJ, and VXUS. I was considering selling some or all of L and CSW.A to add some more international names and was thinking initially of GE and PFE. These changes would be made within an RRSP (the entire portfolio is spread over TFSAs, RRSPs, and RESP).

What are your thoughts on such a move? I should point out that L is less than 1% weighting and CSW.A is approximately 3% of total equity exposure.

Are there other US/International names I should focus on?

Thanks,

Marc
Read Answer Asked by Marc on January 16, 2017